- Recommendation ID
- NG25/7
- Question
At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm birth be started and stopped?
- Any explanatory notes
(if applicable) Preterm birth is a cause of significant morbidity for women and babies, and impacts negatively on women and their families, as well as being costly to the NHS. There is good evidence for the use of progesterone to reduce preterm birth, however studies do not define the optimal gestational age that this treatment should be started and stopped, and it is therefore difficult to recommend when it should started and the optimal duration of treatment.
Source guidance details
- Comes from guidance
- Preterm labour and birth
- Number
- NG25
- Date issued
- November 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/08/2019 |